Ambassador Advisors, LLC Novavax Inc Transaction History

Ambassador Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $70,631 - $199,618	7,972 Added 6.88%	123,884 $1.27 Million
Q3 2022 Nov 18, 2022	BUY	$18.2 - $76.12 $650,995 - $2.72 Million	35,769 Added 44.63%	115,912 $2.11 Million
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $2.26 Million - $4.7 Million	62,401 Added 351.71%	80,143 $4.12 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $137,856 - $282,513	1,977 Added 12.54%	17,742 $1.31 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $284,728 - $461,224	-2,116 Reduced 11.83%	15,765 $2.26 Million
Q3 2021 Nov 16, 2021	SELL	$177.8 - $270.58 $262,610 - $399,646	-1,477 Reduced 7.63%	17,881 $3.71 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $351,505 - $748,531	-2,905 Reduced 13.05%	19,358 $4.11 Million
Q1 2021 May 13, 2021	BUY	$112.98 - $319.93 $2.52 Million - $7.12 Million	22,263 New	22,263 $4.04 Million
Q4 2020 Feb 17, 2021	SELL	$78.74 - $139.5 $2.1 Million - $3.72 Million	-26,663 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $2.12 Million - $4.76 Million	26,663 New	26,663 $2.89 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Ambassador Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ambassador Advisors, LLC with notifications on news.